AzTrials
AzTrials

BalanceBalance - DMNCT07776535

Effects Of Otago Exercise Versus Multisensory Integration Training On Balance And Gait In Elderly With Diabetes

A study testing Otago exercise, Multisensory integration training and conventional treatment for neuropathy in people with Balance and Gait, run by Cairo University at 1 site in Egypt.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to compare the effect of the Otago exercise and Multisensory integration training on balance and gait in the elderly with type 2 diabetes mellitus. Read more about this study

Who is it for?
Ages 65 to 75 years
Conditions the study is for
Balance, Gait, Diabetes Mellitus
What is being tested?
Otago exercise, Multisensory integration training and conventional treatment for neuropathy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
1 siteEgypt
Study dates
Oct 2026to Nov 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 to 75 years
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Ninety elderly Patients of both genders.
  • Their age will range from 65 to 75th.
  • They will be diagnosed with type 2 diabetes for 5 years or more.
  • Patients with mild \& moderate neuropathy will be included. (Based on the Toronto scale: -mild (6-8); moderate (9-11)
  • Berg balance between (21 to <50) patients with mild \&moderate risk of fall .
  • Time up \& go dual task: patient takes longer than 10 sec.
Show all 9Show fewer
  • HBA1C for these patients was ≥ 6.5% .
  • BMI will range from (18: 29,9 kg/m2).
  • Able to walk independently, with or without assistive devices.

Who cannot join

  • Any musculoskeletal disorder affecting the lower limb (fracture of the lower limb, tumors, any infection, ligament injuries, foot injuries).
  • Any other neurological disorder influences gait such as (stroke, Parkinson's disease, cerebellar dysfunction, ataxia, vestibular disorders)
  • Any other cardiovascular disease (arrhythmia, cardiac pacemakers).
  • Unstable proliferative retinopathy and visual impairments without correction.
  • Non-diabetic neuropathy (inflammatory, autoimmune disease, infections, tumors, vitamin B12 deficiency, hypothyroidism, alcoholism, injury or pressure on the nerve).
  • The use of medications significantly impacting postural control (e.g., sedatives).
Show all 10Show fewer
  • Vestibular system and Cognitive disorders.
  • Uncontrolled hypertension.
  • Common peroneal nerve injury.
  • Orthostatic hypotension.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Toka Adel Mohammed Fahmy, physiotherapist contact

+201064030561

pttokaadel@gmail.com

Egypt1 site
  • El-Qenayat Central Hospital

    Zagazig

    Toka Adel Mohammed Fahmy, physiotherapist, +201064030561, pttokaadel@gmail.com

Other trials in Egypt

About this study

The goal of this clinical trial is to compare the effect of the Otago exercise and Multisensory integration training on balance and gait in the elderly with type 2 diabetes mellitus.

The main question it aims to answer is:

Read more
  • Is there a significant difference between the effect of Otago exercise and Multisensory integration training on balance and gait in the elderly with type 2 diabetes mellitus? Researchers will compare Otago exercise to Multisensory integration training to know which one has the greatest benefit on balance \&gait in the elderly with type2 diabetes.

Participants will be divided into 3 groups; each group takes a certain training program for 8 weeks:

  • First group: Otago exercise group plus conventional treatment for neuropathy.
  • Second group: Multisensory integration training group plus conventional treatment for neuropathy.
  • Third group: control group takes only conventional treatment for neuropathy.
Read the detailed description

Diabetes one of the most prevalent chronic non-communicable diseases. Diabetic peripheral neuropathy (DPN) is a prevalent complication of diabetes, affecting about 50% of diabetic patients.

DPN characterized by peripheral nerve dysfunction. It initially presents sensory symptoms like numbness and tingling, which may evolve into pain and heightened sensitivity. Subsequently, motor symptoms such as muscle weakness and coordination difficulties appear, potentially leading to muscle atrophy.

Due to all these changes affecting peripheral nerve function, the functions of the lower extremities will be disturbed, which facilitate normal posture and walking, resulting in a loss of somatosensation and proprioception. This decreased sensitivity in the feet leads to balance defects, particularly in elderly and diabetic individuals.

The Otago exercise program is effective in preventing falls in older adults by improving cognitive function, balance, strength, functional fitness, and recovery, while reducing costs. Furthermore, multisensory exercises enhance balance and mobility by targeting sensory systems, thus lowering fall risk compared to traditional methods focused on physical strength or motor skills.

Both interventions positively affect balance and mobility in older adults with type 2 diabetes, but direct comparisons of their effectiveness are limited. This study aims to fill that gap by evaluating two rehabilitation interventions, potentially aiding clinical decision-making by identifying the more effective option for enhancing postural stability and mobility.

Being tested
Otago exercise, Multisensory integration training, conventional treatment for neuropathy
Keywords
otago exercise, multisensory integration, balance disorder, gait proplem, diabetes, elderly, older adults
Medical subject headings
Diabetes Mellitus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Otago exerciseOther

    Exercise program consisted of ( flexibilty - strengthening - balance ) exercise for elderly.

    Time of each session (50:60 min). For 3d/w for 8weeks.

  • Multisensory integration trainingOther

    Multisensory integration training is a group of balance exercise depend on facilitating different sensory systems (visual-vestibular-propioception) Time for each session (50 min). For 3d/w for 8weeks.

  • conventional treatment for neuropathyOther

    conventional treatment for improving balance and gait problem associated with DPN For 3d/w for 8weeks

Study groups in NCT07776535
Study groupRoleWhat they receive
Otago exercise groupActive comparatorOtago exercise plus conventional treatment for neuropathy. for 3d/w for 8weeks.
Receives: Other: Otago exercise; Other: conventional treatment for neuropathy
Multisensory integration training groupActive comparatorMultisensory integration training group with conventional treatment for neuropathy. for 3d/w for 8 weeks.
Receives: Other: Multisensory integration training; Other: conventional treatment for neuropathy
control groupActive comparatorOnly conventional treatment for neuropathy For 3d/w for 8 weeks.
Receives: Other: conventional treatment for neuropathy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Balance: ( Time up & go test )dual task

    Measured: From enrollment to the end of treatment at 8 weeks

  2. Balance: Berg Balance Scale

    Measured: From enrollment to the end of the treatment at 8 weeks

  3. Gait speed (10m walk test)

    Measured: From enrollment to the end of the treatment at 8 weeks

Secondary outcomes (3)
  1. Functional reach test.

    Measured: From enrollment to the end of treatment at 8 weeks

  2. Modified fall efficacy scale

    Measured: From enrollment to the end of treatment at 8 weeks

  3. Toronto clinical neuropathy score

    Measured: From enrollment to the end of treatment at 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Aug 2026
  2. Study startOct 2026 (estimated)
  3. Primary completionOct 2027 (estimated)
  4. Study completionNov 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
patient will be assigned into three group: * first group: will take Otago exercise plus conventional treatment for neuropathy * second group: will take multisensory integration training plus conventional treatment for neuropathy. * Third group: will only take the conventional treatment for neuropathy.
Masking
Single blind
Who is masked
Participant
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07776535
Sponsor's protocol ID
balance exercise for elderly
Acronym
Balance - DM
Status last verified
Aug 2026
First submitted
9 Aug 2026
Last updated
20 Aug 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Otago exercise, Multisensory integration training and conventional treatment for neuropathy in people with Balance and Gait, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 20 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Toka Adel Mohammed Fahmy, physiotherapist (+201064030561, pttokaadel@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Balance: ( Time up & go test )dual task (time frame: From enrollment to the end of treatment at 8 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in